Two Sigma Advisers
FENC icon

Two Sigma Advisers’s Fennec Pharmaceuticals FENC Stock Holding History

Two Sigma Advisers’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,000
Closed -$100K – 759
2025
Q4 		$100K Buy
+13,000
New +$107K ﹤0.01% 2225
2023
Q2 		– Sell
-34,200
Closed -$285K – 2472
2023
Q1 		$285K Sell
34,200
-20,800
-38% -$193K ﹤0.01% 2157
2022
Q4 		$528K Buy
+55,000
New +$487K ﹤0.01% 1858

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Two Sigma Advisers's FENC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Fennec Pharmaceuticals (FENC) in Q1 2026, closing a stake of 13,000 shares — an estimated $100K sold.

Two Sigma Advisers first reported a position in FENC in Q4 2022 and held it in 3 quarters. The position peaked at $528K in Q4 2022. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Two Sigma Advisers reported no remaining Fennec Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 13,000 Fennec Pharmaceuticals shares in Q1 2026, an estimated $100K.
  • Two Sigma Advisers first reported a position in Fennec Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Two Sigma Advisers's Fennec Pharmaceuticals position peaked at $528K in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.